Millennium Management’s Achieve Life Sciences ACHV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.17M Sell
1,077,338
-281,778
-21% -$1.25M ﹤0.01% 3423
2025
Q4
$6.75M Buy
1,359,116
+1,121,614
+472% +$4.89M ﹤0.01% 2683
2025
Q3
$748K Sell
237,502
-148,698
-39% -$408K ﹤0.01% 4833
2025
Q2
$873K Buy
386,200
+364,098
+1,647% +$1.04M ﹤0.01% 4511
2025
Q1
$59K Buy
+22,102
New +$68.7K ﹤0.01% 5520
2024
Q3
Sell
-18,295
Closed -$86K 6037
2024
Q2
$86K Sell
18,295
-175,343
-91% -$845K ﹤0.01% 5335
2024
Q1
$880K Buy
+193,638
New +$860K ﹤0.01% 4411
2023
Q4
Sell
-23,605
Closed -$102K 6016
2023
Q3
$102K Buy
+23,605
New +$119K ﹤0.01% 5333
2023
Q1
Sell
-30,422
Closed -$75K 6293
2022
Q4
$75K Buy
+30,422
New +$78.1K ﹤0.01% 5662
2021
Q3
Sell
-101,986
Closed -$916K 6715
2021
Q2
$916K Buy
+101,986
New +$971K ﹤0.01% 4744
2021
Q1
Sell
-19,971
Closed -$162K 5837
2020
Q4
$162K Buy
+19,971
New +$169K ﹤0.01% 4915
2020
Q2
Sell
-2,620
Closed -$17K 4119
2020
Q1
$17K Buy
+2,620
New +$25.3K ﹤0.01% 3742
2016
Q1
Sell
-16
Closed -$43K 3216
2015
Q4
$43K Sell
16
-34
-68% -$144K ﹤0.01% 3318
2015
Q3
$245K Buy
50
+34
+213% +$205K ﹤0.01% 3017
2015
Q2
$81K Buy
+16
New +$79.4K ﹤0.01% 3195
2015
Q1
Sell
-10
Closed -$50K 3516
2014
Q4
$50K Sell
10
-6
-38% -$29.3K ﹤0.01% 3831
2014
Q3
$93K Sell
16
-149
-90% -$1.03M ﹤0.01% 3562
2014
Q2
$1.36M Buy
165
+129
+358% +$1.58M ﹤0.01% 2013
2014
Q1
$929K Buy
36
+28
+350% +$688K ﹤0.01% 2275
2013
Q4
$143K Buy
+8
New +$140K ﹤0.01% 3302

Other funds holding ACHV

Millennium Management's ACHV Position: Q1 2026 in Review

Millennium Management reduced its Achieve Life Sciences (ACHV) stake by 21% in Q1 2026, selling an estimated $1.25M and leaving 1,077,338 shares worth $3.17M. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

Millennium Management first reported a position in ACHV in Q4 2013 and has held it in 20 quarters since. The position peaked at $6.75M in Q4 2025. 81 funds tracked by Wall St. Rank hold ACHV as of Q1 2026.

  • Millennium Management held 1,077,338 shares of Achieve Life Sciences worth $3.17M as of Q1 2026.
  • Millennium Management sold 281,778 Achieve Life Sciences shares in Q1 2026, an estimated $1.25M.
  • Achieve Life Sciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3423 holding.
  • Millennium Management first reported a position in Achieve Life Sciences in Q4 2013 and has held it in 20 quarters since.
  • Millennium Management's Achieve Life Sciences position peaked at $6.75M in Q4 2025.
  • 81 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.